Researchers at the University of Sussex, in collaboration with scientists from different institutes worldwide, have ...
Clinical trial demonstrates safety of targeted treatment approach for deadly brain tumor in children
A Phase I clinical trial demonstrated that a targeted approach to treating a deadly brain tumor in children called diffuse intrinsic pontine glioma (DIPG) is safe, reported Weill Cornell Medicine and ...
Prognostic Implications of Codon-Specific KRAS Mutations in Localized and Advanced Stages of Pancreatic Cancer IDH-mutant brainstem gliomas have a characteristic clinical and radiographic phenotype.
SurvivorNet on MSN
'Very promising': New cancer drug, Plixorafenib, shows promise for hard‑to‑treat brain tumors as FDA speeds its development
The U.S. Food and Drug Administration (FDA) has granted plixorafenib a Breakthrough Therapy Designation, signaling accelerated development of this targeted drug for patients with an aggressive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results